Brief: Heron Therapeutics posts Q1 EPS USD -0.27
11/05/2023 21:03
May 11 (Reuters) - Heron Therapeutics Q1 net product sales USD 29.615 million. * Q1 operating expenses USD 62.678 million * Q1 net income USD -32.768 million * Q1 income from operations USD -33.063 million * Q1 EPS USD -0.27
Recent news on Heron Therapeutics
See all newsHeron Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Heron Therapeutics Q2 revenue rises on acute care growth, withdraws 2026 outlook
Heron Therapeutics Inc expected to post earnings of 1 cent a share - Earnings Preview
Brief: U.S. District Court Issues Decision Regarding CINVANTI Patents
Heron Therapeutics' Q1 revenue falls as oncology sales drop